Blue Mountain Announces Launch of Blue Mountain University: A Premier e-Learning Experience for RAM Software Users
October 16, 2024 09:00 ET
|
Blue Mountain
Blue Mountain announces the launch of Blue Mountain University, an eLearning platform for RAM software users to enhance skills, efficiency, and compliance.
Curia Commits to SBTi Net-Zero Standard
October 08, 2024 09:00 ET
|
Curia Global, Inc.
Curia today announced its commitment to set near- and long-term greenhouse gas reductions in line with the Science Based Targets initiative (SBTi).
Blue Mountain and Apprentice.io Announce Groundbreaking Integration of EAM and MES Technologies, Transforming Asset Performance Management for Life Sciences Manufacturing
October 03, 2024 09:00 ET
|
Blue Mountain; Apprentice.io
Blue Mountain & Apprentice.io announce groundbreaking integration of EAM & MES technologies for life sciences manufacturers.
Monthly information on share capital and company voting rights
October 02, 2024 16:30 ET
|
Cellectis Inc.
PARIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Big4Bio Names David J. Whelan Its New Chief Business Officer
October 02, 2024 07:30 ET
|
BigBio Communications
SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- BigBio Communications is excited to announce that it is expanding the Big4Bio leadership team with the appointment of David J. Whelan as Chief...
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
September 26, 2024 16:03 ET
|
NurExone Biologic Inc
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
Pivotal Hits Industry Milestone, Surpassing 1,000 Crewed eVTOL Flights
September 25, 2024 08:00 ET
|
Pivotal
Pivotal, the leader in light electric Vertical Takeoff and Landing (eVTOL) aircraft, has achieved 1,117 crewed flights in its BlackFly, a category first
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
September 24, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
September 19, 2024 08:00 ET
|
Helsinn Healthcare S.A.
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors Lugano, Switzerland – September 19, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of...
CSL schließt sich Accumulus Synergy an, um den Wandel der Branche voranzutreiben
September 17, 2024 09:05 ET
|
Accumulus Synergy
BURLINGAME, Kalifornien, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. („Accumulus“) und seine Gründungssponsoren sind stolz darauf, CSL als erstes Mitgliedsunternehmen begrüßen zu...